- Home
- ZYME vs SEDG Comparison
ZYME vs SEDG Comparison
Compare ZYME & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- SEDG
- Stock Information
- Founded
- ZYME 2003
- SEDG 2006
- Country
- ZYME United States
- SEDG Israel
- Employees
- ZYME N/A
- SEDG N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- SEDG Semiconductors
- Sector
- ZYME Health Care
- SEDG Technology
- Exchange
- ZYME Nasdaq
- SEDG Nasdaq
- Market Cap
- ZYME 751.6M
- SEDG 682.3M
- IPO Year
- ZYME 2017
- SEDG 2015
- Fundamental
- Price
- ZYME $13.23
- SEDG $15.77
- Analyst Decision
- ZYME Buy
- SEDG Hold
- Analyst Count
- ZYME 6
- SEDG 26
- Target Price
- ZYME $18.83
- SEDG $26.82
- AVG Volume (30 Days)
- ZYME 416.1K
- SEDG 4.9M
- Earning Date
- ZYME 10-31-2024
- SEDG 11-06-2024
- Dividend Yield
- ZYME N/A
- SEDG N/A
- EPS Growth
- ZYME N/A
- SEDG N/A
- EPS
- ZYME N/A
- SEDG N/A
- Revenue
- ZYME $62,199,000.00
- SEDG $1,046,751,000.00
- Revenue This Year
- ZYME $21.53
- SEDG N/A
- Revenue Next Year
- ZYME N/A
- SEDG $26.62
- P/E Ratio
- ZYME N/A
- SEDG N/A
- Revenue Growth
- ZYME N/A
- SEDG N/A
- 52 Week Low
- ZYME $7.97
- SEDG $10.24
- 52 Week High
- ZYME $17.70
- SEDG $103.15
- Technical
- Relative Strength Index (RSI)
- ZYME 42.19
- SEDG 54.20
- Support Level
- ZYME $12.43
- SEDG $12.27
- Resistance Level
- ZYME $14.10
- SEDG $14.95
- Average True Range (ATR)
- ZYME 0.63
- SEDG 1.29
- MACD
- ZYME -0.10
- SEDG 0.22
- Stochastic Oscillator
- ZYME 26.50
- SEDG 72.05
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.